{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T19:40:18Z","timestamp":1729453218005,"version":"3.27.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.7759\/cureus.71942","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T19:11:45Z","timestamp":1729451505000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Lipid Profile Management in Coronary Artery Disease Patients on Statin Therapy: A Single-Centre, Retrospective, Observational Study"],"prefix":"10.7759","author":[{"given":"C","family":"Sridevi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susheel","family":"Malani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash H","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digvijay D","family":"Nalawade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Shokeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America","volume":"48","author":"Enas EA","year":"1996","unstructured":"Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996, 48:343-53.","journal-title":"Indian Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016","volume":"6","year":"2018","unstructured":"The changing patterns of cardiovascular diseases and their risk factors in the states of India. the Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018, 6:e1339-51. 10.1016\/S2214-109X(18)30407-8","journal-title":"Lancet Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2014.12.001","article-title":"Consensus statement on management of dyslipidemia in Indian subjects","volume":"66 Suppl 3","author":"Chandra KS","year":"2014","unstructured":"Chandra KS, Bansal M, Nair T, et al.. Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J. 2014, 66 Suppl 3:S1-51. 10.1016\/j.ihj.2014.12.001","journal-title":"Indian Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.126532","article-title":"Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease","volume":"18","author":"Mahalle N","year":"2014","unstructured":"Mahalle N, Garg MK, Naik SS, Kulkarni MV. Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian J Endocrinol Metab. 2014, 18:48-55. 10.4103\/2230-8210.126532","journal-title":"Indian J Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns","volume":"129","author":"Frank AT","year":"2014","unstructured":"Frank AT, Zhao B, Jose PO, Azar KM, Fortmann SP, Palaniappan LP. Racial\/ethnic differences in dyslipidemia patterns. Circulation. 2014, 129:570-9. 10.1161\/CIRCULATIONAHA.113.005757","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti J","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al.. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020, 41:407-77. 10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313245","article-title":"Cholesterol-lowering agents","volume":"124","author":"Hadjiphilippou S","year":"2019","unstructured":"Hadjiphilippou S, Ray KK. Cholesterol-lowering agents. Circ Res. 2019, 124:354-63. 10.1161\/CIRCRESAHA.118.313245","journal-title":"Circ Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5455\/ijmsph.2016.28012015229","article-title":"Prevalence and determinants of systemic hypertension among 15-year and older respondents in a rural area of Kancheepuram district, Tamil Nadu-a cross-sectional study","volume":"5","author":"Venkatachalam J","year":"2016","unstructured":"Venkatachalam J, Prasad RV, Kumar TM, Samuel AK, Zile Singh ZS. Prevalence and determinants of systemic hypertension among 15-year and older respondents in a rural area of Kancheepuram district, Tamil Nadu-a cross-sectional study. Int J Med Sci Public Health. 2016, 5:1433-7. 10.5455\/ijmsph.2016.28012015229","journal-title":"Int J Med Sci Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee E","year":"2005","unstructured":"Lee E, Ryan S, Birmingham B, et al.. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005, 78:330-41. 10.1016\/j.clpt.2005.06.013","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report","volume":"106","year":"2002","unstructured":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002, 106.3143-421.","journal-title":"Circulation"},{"key":"ref11","article-title":"IRIS (Indian Reduction in LDL-Cholesterol through Statins) study: efficacy and safety of statins in Indian patients","volume":"62","author":"Joshi SR","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, et al.. IRIS (Indian Reduction in LDL-Cholesterol through Statins) study: efficacy and safety of statins in Indian patients. J Assoc Physicians India. 2014, 62:378-85.","journal-title":"J Assoc Physicians India"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"Waters DD","year":"2011","unstructured":"Waters DD, Ho JE, DeMicco DA, et al.. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol. 2011, 57:1535-45. 10.1016\/j.jacc.2010.10.047","journal-title":"J Am Coll Cardiol"},{"key":"ref13","article-title":"Coronary artery disease in South Asians: evolving strategies for treatment and prevention","volume":"57","author":"Deedwania P","year":"2005","unstructured":"Deedwania P, Singh V. Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J. 2005, 57:617-31.","journal-title":"Indian Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.32553\/ijmbs.v4i9.1398","article-title":"The status of lipid profile control in coronary artery disease patients at a tertiary care hospital","volume":"4","author":"Agarwal AK","year":"2020","unstructured":"Agarwal AK, Meena DS, Pathak V, Jain A, Ola RK. The status of lipid profile control in coronary artery disease patients at a tertiary care hospital. Int J Med Biomed Studies. 2020, 4:6-10. 10.32553\/ijmbs.v4i9.1398","journal-title":"Int J Med Biomed Studies"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz GG","year":"2001","unstructured":"Schwartz GG, Olsson AG, Ezekowitz MD, et al.. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001, 285:1711-8. 10.1001\/jama.285.13.1711","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon CP","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, et al.. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004, 350:1495-504. 10.1056\/NEJMoa040583","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen TR","year":"2005","unstructured":"Pedersen TR, Faergeman O, Kastelein JJ, et al.. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005, 294:2437-45. 10.1001\/jama.294.19.2437","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref19","article-title":"Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study [Article in Spanish]","volume":"61","author":"Orozco-Beltr\u00e1n D","year":"2008","unstructured":"Orozco-Beltr\u00e1n D, Brotons C, Moral I, et al.. Factors affecting the control of blood pressure and lipid levels in patients with cardiovascular disease: the PREseAP Study [Article in Spanish]. Rev Esp Cardiol. 2008, 61:317-21.","journal-title":"Rev Esp Cardiol"},{"key":"ref20","article-title":"Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus","volume":"29","author":"Bawah AT","year":"2020","unstructured":"Bawah AT, Darko R, Abaka-Yawson A, Seini MM, Kinanyok S, Adusei S. Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus. J Pub Health. 2020, 29:985-91.","journal-title":"J Pub Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.04.030","article-title":"Prevalence of poor lipid control in patients with premature coronary artery disease","volume":"30","author":"Froylan D MS","year":"2020","unstructured":"Froylan D MS, Esteban JG, Carlos PR, Aida X MU, Ma Roc\u00edo MA, Horacio OA, Juan G JR. Prevalence of poor lipid control in patients with premature coronary artery disease. Nutr Metab Cardiovasc Dis. 2020, 30:1697-705. 10.1016\/j.numecd.2020.04.030","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2016.02.012","article-title":"Degree of lipid control in patients with coronary heart disease and measures adopted by physicians. REPAR Study","volume":"69","author":"Galve E","year":"2016","unstructured":"Galve E, Cordero A, Cequier A, Ruiz E, Gonz\u00e1lez-Juanatey JR. Degree of lipid control in patients with coronary heart disease and measures adopted by physicians. REPAR Study. Rev Esp Cardiol (Engl Ed). 2016, 69:931-8. 10.1016\/j.rec.2016.02.012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9880.C1.027","article-title":"Poor lipid control among coronary heart disease patients receiving statins in India","volume":"6","author":"Chatruvedi H","year":"2015","unstructured":"Chatruvedi H. Poor lipid control among coronary heart disease patients receiving statins in India. J Clin Exp Cardiol. 2015, 6:110. 10.4172\/2155-9880.C1.027","journal-title":"J Clin Exp Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/299960-evaluation-of-lipid-profile-management-in-coronary-artery-disease-patients-on-statin-therapy-a-single-centre-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T19:11:47Z","timestamp":1729451507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/299960-evaluation-of-lipid-profile-management-in-coronary-artery-disease-patients-on-statin-therapy-a-single-centre-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.71942","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,20]]}}}